Pharmaceutical

STAT+: HHS names inaugural chief competition officer

Stacy Sanders will be HHS' first chief competition officer, a position created a...

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit...

Backed by Mayo Clinic and Microsoft, a new nonprofit venture will oversee a nati...

Opinion: Americans are obsessed with health and fitness...

Americans are obsessed with health and fitness tracking. It’s time for a data diet.

Opinion: Cost isn’t the only reason Medicare doesn’t co...

Cost isn’t the only reason why Medicare doesn’t cover weight loss drugs.

Opinion: STAT readers on Census data, nutrition educati...

STAT readers weigh in on inhalable epinephrine as an alternative to EpiPens, nut...

Biden’s FDA is letting Ron DeSantis import cheaper drug...

The Biden administration approved Florida Gov. Ron DeSantis’ plan to import a li...

STAT+: GSK is replacing its popular Flovent inhaler wit...

By discontinuing the brand-name Flovent inhaler but continuing to earn money fro...

Why did Allogene cancel two clinical trials for its off...

Today's Readout newsletter: Allogene changes gears, Illumina exec leaves to beco...

STAT+: Pharmalittle: We’re reading about Lilly selling ...

Eli Lilly started an online service offering telehealth prescriptions and direct...

Opinion: I went on a mind-boggling journey to get my so...

One man’s mind-boggling journey to get his son’s necessary ADHD medication cover...

Opinion: The misguided reason why providers aren’t pres...

Providers shouldn’t be afraid of buprenorphine for opioid use disorder making it...

A young dancer, diagnosed with scoliosis, learns to adv...

Caught during a screening at school, a young dancer's diagnosis of scoliosis led...

Pharmaceutical Technology Excellence Awards 2023: KAI C...

KAI, a technology company based in the UK, is a Category Award Winner for Innova...

Rhythm expands obesity portfolio with Phase II weight l...

Rhythm to acquire global rights for South Korean LG Chem’s oral obesity drug LB5...

Boehringer and 3T Biosciences partner to develop cancer...

Boehringer Ingelheim has signed a deal with 3T Biosciences for the discovery and...

Avistone raises $140m to support drug research and deve...

Avistone has closed its Series B financing round, raising 1bn yuan ($140m), to s...